EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

The Epidemiology of Hepatitis E in Israel and Potential Risk Factors: A Cross-Sectional Population-Based Serological Survey of Hepatitis E Virus in Northern Israel

Rasha Daniel, Shira Zelber-Sagi iD, Mira Barak, Eli Zuckerman

Viruses · 2025

DOI: 10.3390/v17040536 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Viruses, 2025. Verfasst von Rasha Daniel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Haifa and Western Galilee Central Laboratories, Clalit Health Services, Nesher 20300, Israel. Hauptthemen laut MEDLINE: Hepatitis E, Hepatitis E virus, Hepatitis Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis E Virus (HEV) has gained public health attention as one of the causative agents of viral hepatitis. Our study aimed to provide data about HEV seropositivity in the Israeli general population, including its seroprevalence geographical distribution, and to identify variables as possible risk factors for HEV exposure. A seroprevalence cross-sectional study was conducted: HEV serological status was determined in 716 blood samples collected from the routine check-up blood samples. Demographic information was available for all samples. The overall prevalence of HEV IgG in an apparently healthy population in the north of Israel was 10.5%, with no evidence of positive HEV IgM. There was a significant association between HEV seropositivity and elderly age and low socioeconomic status (SES). The age-adjusted seroprevalence was significantly lower among Jews compared to Arabs with a rate ratio of 2.02. We identified clusters (hot spots) of HEV infection in three regions under study. Our results confirmed a high prevalence of anti-HEV in the country where clinical hepatitis E is not endemic. For the first time, this study showed that a hot spot analysis was able to provide new knowledge about actual exposure zones. As HEV infection is not a notifiable disease, it is probably underdiagnosed. Thus, better awareness among physicians is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis EHepatitis E virusHepatitis AntibodiesHumansIsraelSeroepidemiologic StudiesCross-Sectional StudiesFemaleMaleMiddle AgedRisk FactorsAdultAgedImmunoglobulin GAdolescentYoung AdultImmunoglobulin MPrevalenceChildAged, 80 and overChild, Preschool

Stichwörter der Autor:innen

general populationhepatitis E virushot spot analysisseroprevalence

Substanzen

Immunoglobulin GHepatitis AntibodiesImmunoglobulin M

Autor:innen und Institutionen

  • Haifa and Western Galilee Central Laboratories, Clalit Health Services, Nesher 20300, Israel.
  • School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa 3498838, Israel.
  • Head of Medical Laboratory Sciences, Zefat Academic College, Safed 13206, Israel.
  • Liver Unit, Carmel Medical Center, Faculty of Medicine, Technion Institute, Haifa 3498838, Israel.

ORCID-Profile: Shira Zelber-Sagi

Zitieren

APA

Daniel, R., Zelber-Sagi, S., Barak, M., & Zuckerman, E. (2025). The Epidemiology of Hepatitis E in Israel and Potential Risk Factors: A Cross-Sectional Population-Based Serological Survey of Hepatitis E Virus in Northern Israel. Viruses. https://doi.org/10.3390/v17040536

Vancouver

Daniel R, Zelber-Sagi S, Barak M, Zuckerman E. The Epidemiology of Hepatitis E in Israel and Potential Risk Factors: A Cross-Sectional Population-Based Serological Survey of Hepatitis E Virus in Northern Israel. Viruses. 2025. doi:10.3390/v17040536

BibTeX
@article{Daniel2025,
  author = {Daniel, Rasha and Zelber-Sagi, Shira and Barak, Mira and Zuckerman, Eli},
  title = {The Epidemiology of Hepatitis E in Israel and Potential Risk Factors: A Cross-Sectional Population-Based Serological Survey of Hepatitis E Virus in Northern Israel},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17040536}
}
Kostenlos starten →